Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: The HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial

JACC: Cardiovascular Interventions

Volumn 4, Issue 9, 2011, Pages 1011-1019

  Saltzman, Adam J ^a   Stone, Gregg W ^a   Claessen, Bimmer E ^a   Narula, Amar ^a   Leon Reyes, Selene ^a   Weisz, Giora ^a   Brodie, Bruce ^c   Witzenbichler, Bernhard ^d   Guagliumi, Giulio ^e   Kornowski, Ran ^f   Dudek, Dariusz ^g   Metzger, D Christopher ^h   Lansky, Alexandra J ^a   Nikolsky, Eugenia ^a   Dangas, George D ^b   Mehran, Roxana ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MOSES H CONE MEMORIAL HOSPITAL   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e OSPEDALI RIUNITI   (Italy)

^f RABIN MEDICAL CENTER   (Israel)

^g JAGIELLONIAN UNIVERSITY   (Poland)

^h Heart Center   (United States)

Author keywords

bivalirudin; chronic kidney disease; ST segment elevation myocardial infarction

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL; TAXUS EXPRESS; TICLOPIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIAC PATIENT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEATH; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEART REINFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; THROMBOSIS;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DRUG-ELUTING STENTS; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HEPARIN; HIRUDINS; HUMANS; ISRAEL; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECOMBINANT PROTEINS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 80052971867     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.06.012     Document Type: Article

References (30)

1. P.J. Best, R. Lennon, and H.H. Ting The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 2002 1113 1119 (Pubitemid 34267412)
2. J.L. Januzzi Jr., S.M. Snapinn, P.M. DiBattiste, I.K. Jang, and P. Theroux Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial Circulation 105 2002 2361 2366 (Pubitemid 34556386)
3. P.B. Berger, P.J. Best, and E.J. Topol The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the Do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial Am Heart J 149 2005 869 875 (Pubitemid 40718884)
4. P.A. Lemos, C.A. Arampatzis, and A. Hoye Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents Am J Cardiol 95 2005 167 172 (Pubitemid 40092079)
5. D.J. Blackman, R. Pinto, and J.R. Ross Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention Am Heart J 151 2006 146 152 (Pubitemid 41815345)
6. G.S. Hillis, B.L. Croal, and K.G. Buchan Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up Circulation 113 2006 1056 1062
7. J.H. Han, A. Chandra, and J. Mulgund Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes Am J Med 119 2006 248 254 (Pubitemid 43255066)
8. D.P. Chew, D.L. Bhatt, and W. Kimball Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials Am J Cardiol 92 2003 919 923 (Pubitemid 37214802)
9. S. Vasu, L. Gruberg, and D.L. Brown The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction Catheter Cardiovasc Interv 70 2007 701 705 (Pubitemid 350144451)
10. F. Latif, N.S. Kleiman, and D.J. Cohen In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry J Am Coll Cardiol Intv 2 2009 37 45
11. C.S. Fox, P. Muntner, and A.Y. Chen Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry Circulation 121 2010 357 365
12. I. Goldenberg, I. Subirana, and V. Boyko Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project Arch Intern Med 170 2010 888 895
13. R. Mehran, E. Nikolsky, and A.J. Lansky Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy J Am Coll Cardiol Intv 2 2009 748 757
14. A. Grand'Maison, A.F. Charest, and W.H. Geerts Anticoagulant use in patients with chronic renal impairment Am J Cardiovasc Drugs 5 2005 291 305 (Pubitemid 41306468)
15. J. Ezekowitz, F.A. McAlister, and K.H. Humphries The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease J Am Coll Cardiol 44 2004 1587 1592 (Pubitemid 39369790)
16. D.P. Chew, A.M. Lincoff, and H. Gurm Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial) Am J Cardiol 95 2005 581 585 (Pubitemid 40255244)
17. M.D. Reed, and D. Bell Clinical pharmacology of bivalirudin Pharmacotherapy 22 2002 105S 111S (Pubitemid 34596472)
18. A. Sagripanti, V. Cozza, U. Baicchi, M. Camici, A. Cupisti, and G. Barsotti Increased thrombin generation in patients with chronic renal failure Int J Clin Lab Res 27 1997 72 75
19. G.W. Stone, B. Witzenbichler, and G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230 (Pubitemid 351724451)
20. R. Mehran, A.J. Lansky, and B. Witzenbichler Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
21. R. Mehran, B. Brodie, and D.A. Cox The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial: study design and rationale Am Heart J 156 2008 44 56 (Pubitemid 351862292)
22. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
23. Nutritional anaemias Report of a WHO scientific group World Health Organ Tech Rep Ser 405 1968 5 37
24. A. Goldberg, E. Kogan, H. Hammerman, W. Markiewicz, and D. Aronson The impact of transient and persistent acute kidney injury on long-term outcomes after acute myocardial infarction Kidney Int 76 2009 900 906
25. M. Seyfarth, A. Kastrati, and J.F. Mann Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention Am J Kidney Dis 54 2009 830 839
26. R.S. Wright, G.S. Reeder, and C.A. Herzog Acute myocardial infarction and renal dysfunction: a high-risk combination Ann Intern Med 137 2002 563 570
27. D.J. Goldsmith, and A. Covic Coronary artery disease in uremia: etiology, diagnosis, and therapy Kidney Int 60 2001 2059 2078 (Pubitemid 33070450)
28. A. Sagripanti, and G. Barsotti Bleeding and thrombosis in chronic uremia Nephron 75 1997 125 139 (Pubitemid 27064854)
29. G.W. Stone, J.H. Ware, and M.E. Bertrand Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial JAMA 298 2007 2497 2506 (Pubitemid 350223536)
30. A.M. Lincoff, N.S. Kleiman, and D.J. Kereiakes Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial JAMA 292 2004 696 703 (Pubitemid 39062523)